Abstract: Biodegradable polymeric microparticle compositions containing one or more active agents, especially those useful for treating or preventing or one or more diseases or disorders of the eye, and methods of making and using thereof, are described. The microsphere compositions release an effective amount of the one or more active agents for a period greater than 14 days in vivo, preferably greater than 60 days in vivo, more preferably up to 73 days in vivo, more preferably greater than 90 days in vivo, even more preferably over 100 days in vivo, and most preferably greater than 107 days in vivo. In a preferred embodiment, the microparticle compositions contain one or more active agents useful for managing elevated intraocular pressure (TOP) in the eye. In one embodiment, the microspheres are formed from polylactide-co-glycolide (“PLGA”); in another embodiment, the microspheres are formed from a blend PLGA and poly lactic acid (“PLA”).

Abstract: A self-defense flashlight includes sharp edges positioned around the head end. A sharp edge protector can be positioned so as to surround and protect the sharp edges, when the flashlight is not being used for self-defense purposes. When needed, the sharp edge protector can be moved so as to expose the sharp edges, allowing the flashlight to be used as a weapon. The protectable sharp edges can also be positioned around the tail end of the self-defense flashlight.

Abstract: The present invention provides a method of decreasing side effects in a human or animal cancer patient due to radiation therapy or chemotherapy. With this method, methionine enkephalin is administered to the patient at least one time per week for a first time period, where the first time period is at least three weeks. In one embodiment, the first time period is one or two months. Methionine enkephalin is then administered to the patient one time per month for a second time period, where the second time period is at least one month, and where the second time period is consecutive to the first time period. In one embodiment, the total term of methionine enkephalin treatment is at least six months. Methionine enkephalin may be administered to the patient at the same time as, before, or after administration of radiation or chemotherapy.

Abstract: A rechargeable flashlight uses induction for charging, and thus does not utilize external contacts. The flashlight is cylindrically shaped, and has a secondary coil wrapped around a portion of the cylindrical body. The flashlight is placed within a ring shaped charger with a primary coil, such that the primary coil is wrapped around the secondary coil. This greatly maximizes the amount of interfacing area between the two coils, without adversely affecting the reflector design. This allows for the charging of a high powered flashlight, without requiring the flashlight to have a disadvantageously sized or constructed head. Furthermore, the primary coil of the charger can advantageously serve as a mechanical support for the flashlight.

Abstract: The present invention provides a method of stimulating dendritic cells, comprising contacting the dendritic cells with methionine enkephalin. The present invention also provides methods of enhancing an immune response to an antigen in a mammal. In a first method, dendritic cells are isolated from the mammal. The dendritic cells are then contacted with methionine enkephalin for a time sufficient to stimulate the cells. Next, the stimulated dendritic cells are contacted with the antigen of interest for a time sufficient for the cells to process the antigen. The dendritic cells are then injected into the mammal. The dendritic cells may be injected into the animal either on their own, or along with methionine enkephalin and/or the antigen. In a second method, the antigen of interest and methionine enkephalin are administered to the mammal. The present invention also provides compositions for administration to a mammalian subject having a tumor.

Abstract: Micro-electro-mechanical system (MEMS) variable capacitors and actuation components and related methods are provided. A MEMS variable capacitor can include first and second feed lines extending substantially parallel to one another. Further, MEMS variable capacitors can include first and second capacitive plates being spaced apart from the first and second feed lines. The first and second capacitive plates can be separately movable with respect to at least one of the first and second feed lines for varying the capacitance between the first and second feed lines over a predetermined capacitance range.

Abstract: A medication management system (MMS) includes a medication management unit (MMU) associated with a medical device. The MMU downloads a medication order to the medical device only if information from a first input matches information from a second input. The medical device receives delivery information only from the MMU. The medication order is performed only after delivery data validation. The MMU also determines drug-drug incompatibility. The MMU can modulate (start, stop, and dynamically adjust) medication order performance. The medical device wirelessly receives a patient ID to automatically associate with the patient. During delivery, the medical device caches an updated drug library to replace an existing one. The medical device displays a patient picture for validation. The MMU evaluates the performance of medical devices and caregivers based medical device feedback. The MMU adjusts the output of medical device information conveyed to a caregiver.

Abstract: A medication management system (MMS) includes a medication management unit (MMU) associated with a medical device. The MMU downloads a medication order to the medical device only if information from a first input matches information from a second input. The medical device receives delivery information only from the MMU. The medication order is performed only after delivery data validation. The MMU also determines drug-drug incompatibility. The MMU can modulate (start, stop, and dynamically adjust) medication order performance. The medical device wirelessly receives a patient ID to automatically associate with the patient. During delivery, the medical device caches an updated drug library to replace an existing one. The medical device displays a patient picture for validation. The MMU evaluates the performance of medical devices and caregivers based medical device feedback. The MMU adjusts the output of medical device information conveyed to a caregiver.

Abstract: A medication management system (MMS) includes a medication management unit (MMU) associated with a medical device. The MMU downloads a medication order to the medical device only if information from a first input matches information from a second input. The medical device receives delivery information only from the MMU. The medication order is performed only after delivery data validation. The MMU also determines drug-drug incompatibility. The MMU can modulate (start, stop, and dynamically adjust) medication order performance. The medical device wirelessly receives a patient ID to automatically associate with the patient. During delivery, the medical device caches an updated drug library to replace an existing one. The medical device displays a patient picture for validation. The MMU evaluates the performance of medical devices and caregivers based medical device feedback. The MMU adjusts the output of medical device information conveyed to a caregiver.

Abstract: A method and apparatus is disclosed for operating a medical device with a screen having an improved graphical user interface, which selectively reallocates screen display for both single and multi-channel pumps. Channel indicators associate operation information with a specific delivery channel. Patient or drug order verification is facilitated with a rendering of the patient or the entire drug order/label on the screen. Decimal numbers are presented in vertically offset decimal format. A dual function button cancels the current operation and, after a delay, clears entered parameters. An area sensitive scrollbar cycles through information at various speeds. Screen brightness is adjusted based on an ambient light detector. A screen saver mode activates based on several operating conditions. The screen is incorporated in a removable user interface.

Abstract: A medication management system (MMS) includes a medication management unit (MMU) associated with a medical device. The MMU downloads a medication order to the medical device only if information from a first input matches information from a second input. The medical device receives delivery information only from the MMU. The medication order is performed only after delivery data validation. The MMU also determines drug-drug incompatibility. The MMU can modulate (start, stop, and dynamically adjust) medication order performance. The medical device wirelessly receives a patient ID to automatically associate with the patient. During delivery, the medical device caches an updated drug library to replace an existing one. The medical device displays a patient picture for validation. The MMU evaluates the performance of medical devices and caregivers based medical device feedback. The MMU adjusts the output of medical device information conveyed to a caregiver.

Abstract: A medication management system (MMS) includes a medication management unit (MMU) associated with a medical device. The MMU downloads a medication order to the medical device only if information from a first input matches information from a second input. The medical device receives delivery information only from the MMU. The medication order is performed only after delivery data validation. The MMU also determines drug-drug incompatibility. The MMU can modulate (start, stop, and dynamically adjust) medication order performance. The medical device wirelessly receives a patient ID to automatically associate with the patient. During delivery, the medical device caches an updated drug library to replace an existing one. The medical device displays a patient picture for validation. The MMU evaluates the performance of medical devices and caregivers based medical device feedback. The MMU adjusts the output of medical device information conveyed to a caregiver.

Abstract: A medication management system (MMS) includes a medication management unit (MMU) associated with a medical device. The MMU downloads a medication order to the medical device only if information from a first input matches information from a second input. The medical device receives delivery information only from the MMU. The medication order is performed only after delivery data validation. The MMU also determines drug-drug incompatibility. The MMU can modulate (start, stop, and dynamically adjust) medication order performance. The medical device wirelessly receives a patient ID to automatically associate with the patient. During delivery, the medical device caches an updated drug library to replace an existing one. The medical device displays a patient picture for validation. The MMU evaluates the performance of medical devices and caregivers based medical device feedback. The MMU adjusts the output of medical device information conveyed to a caregiver.

Abstract: A medication management system (MMS) includes a medication management unit (MMU) associated with a medical device. The MMU downloads medication delivery code based on a medication delivery order to the medical device only if information from a first input matches information from a second input. The medical device receives delivery information electronically only from the MMU. The medication order is performed only after delivery data validation. The MMU also determines drug-drug incompatibility. The MMU can modulate (start, stop, sequence and dynamically adjust) medication order performance.

Abstract: An electrochemical cell including a cathode, an electrolyte in ionic contact with the cathode, and an anode in physical contact with the electrolyte, wherein the anode contains a controlled release anode composition that includes at least a first anode active material and at least a first controlled release agent in physical contact thereto for tentatively isolating the first anode active material from the electrolyte in the beginning of a cell operation for a delayed reaction of the first anode active material. Preferably, the anode further contains an initial-stage anode active material in direct contact with the electrolyte. Such a controlled release anode can be used in a variety of electrochemical cells including metal-air batteries, such as a zinc-air battery, for an extended period of operating time.

Abstract: A telecommunication communicating facility have two or more wireless network access devices to be communicated with network systems with a single LAN. One of the wireless network access devices includes a processor unit having a detecting device to detect and to receive signals from the other wireless network access devices and end users, and to adjust the frequency or the identification of the wireless network access devices, for allowing the access devices to be communicatable with each other and to be communicatable with the end users.

Abstract: An antenna for a tire pressure detector is installed on an RF circuit board of the tire pressure detector. The antenna has a seat with a bottom plate. A post is uprightly formed on the bottom plate. A plurality of positioning members evenly formed at an outer periphery of the post. A wire electrically connected with the RF circuit board is coiled round the post and positioned in the positioning members. A cover has a body provided outside the seat. A bolt is inserted through the cover to fasten the antenna on the RF circuit board. The antenna has a low manufacturing cost, and is convenient to be installed.

Abstract: Hydrogenated block copolymers are used as a component in a cold flow additive composition.

Abstract: An antenna for a tyre pressure detector is installed on an RF circuit board of the tyre pressure detector. The antenna has a seat with a bottom plate. A post is uprightly formed on the bottom plate. A plurality of positioning members evenly formed at an outer periphery of the post. A wire electrically connected with the RF circuit board is coiled round the post and positioned in the positioning members. A cover has a body provided outside the seat. A bolt is inserted through the cover to fasten the antenna on the RF circuit board. The antenna has a low manufacturing cost, and is convenient to be installed.

Abstract: A controlling facility for a network system includes a processor unit having a detecting device to detect and to check identification of end users and to determine whether the end users are acceptable or qualified or not. One or more comparing devices may be used to compare data of the end users and to determine whether the end users are busy or not. An operating device may be used to reject the unbusy end users and to couple the end users to unused access device, for allowing the transmitting operation to be conducted more fluently or smoothly.